Francesco Fera rises to the top of the Italian Medicines Agency (Aifa), taking over, as acting, from the resigning president Giorgio Palù. The new AIFA Regulation, in fact, provides that in the event of the president’s absence or impediment, the member of the Board of Directors appointed by the Ministry of Health, Francesco Fera, will temporarily take over the functions. Sources from the Ministry of Health confirmed this to ANSA. Fera is currently director of the complex administrative management area structure of the strategic regional agency for health and social care (Aress) of Puglia.
Fera, a law graduate, is a healthcare manager specialized in performance management. After Palù’s controversial resignation, he will therefore be the one to lead, at least for now, the Italian Medicines Agency. This opens a transition phase for the new Aifa, born from the recent reform strongly supported by Palù himself. According to the new Regulation, which came into force on 30 January, “in the event of the president’s absence or legitimate impediment – states article 6 – his functions are temporarily carried out by the board member designated by the Minister of Health“. The Regulation also provides that, upon proposal of the Minister of Health, an Extraordinary Commissioner may be appointed who must ensure ordinary management and temporarily assumes the powers of the President of the Board of Directors, who is also President, for a maximum period of three months. of Aifa. The president is instead appointed through a decree of the Minister of Health, in agreement with the State-Regions Conference, and with the consent of the Minister of Economy.
breaking latest news © Copyright ANSA